This was more evident when we focused our analyses on the putative tumor-targeting CD8+CD39+ subpopulations33, 34, where SOX4 knockdown resulted in a reduction in the PD1+CD39+CD8+ TILs subpopulation (Fig. 5e and Supplementary Fig. 5j). This evidence concerns the gene CD8A and neoplasm.